These findings underscore the significance of monitoring adaptive features in LC subjects, especially focusing on CD8 T cells and gamma delta T cell parameters, which may contribute to distinguishing LC patients from HD/Recovered subjects. This evidence concerns the gene CD8A and Huntington disease.